Several drug companies, including Amgen and the team of Regeneron and Sanofi, are developing incredibly potent cholesterol shots that work by targeting a protein called PCSK9.
Organon chemist Anton Bom had the radical idea of making a drug that targets another drug, rather than targeting a protein, as just about every other drug on the market does.